Marwa E Elsherbiny, Ayman O S El-Kadi, Dion R Brocks
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
Drug metabolism letters 2010 JanDesethylamiodarone was reported to inactivate human CYP1A1. To assess this, two protocols were implemented employing dilution and non-dilution of the preincubation mixture. Inactivation studies performed with diluted preincubation mixtures showed no inactivation of CYP1A1 by desethylamiodarone. However there was evidence for a mixed competitive inhibition (competitive and the uncompetitive inhibition constants of 2.1 microM and 9.6 microM, respectively) of CYP1A1 by desethylamiodarone. NADPH addition and/or replenishment were found to be important factors in determining the control activity in inactivation studies.
Marwa E Elsherbiny, Ayman O S El-Kadi, Dion R Brocks. Assessment of the inactivation potential of desethylamiodarone on human CYP1A1. Drug metabolism letters. 2010 Jan;4(1):9-14
PMID: 20201781
View Full Text